Detalhe da pesquisa
1.
A randomized phase 2 trial of oral vitamin A for graft-versus-host disease in children and young adults.
Blood
; 143(12): 1181-1192, 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38227933
2.
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need.
Blood
; 141(6): 567-578, 2023 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36399715
3.
Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML.
Blood
; 139(24): 3546-3557, 2022 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35286378
4.
PP2A is a therapeutically targetable driver of cell fate decisions via a c-Myc/p21 axis in human and murine acute myeloid leukemia.
Blood
; 139(9): 1340-1358, 2022 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34788382
5.
Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm.
N Engl J Med
; 380(17): 1628-1637, 2019 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31018069
6.
NCCN Guidelines® Insights: Hematopoietic Growth Factors, Version 1.2022.
J Natl Compr Canc Netw
; 20(5): 436-442, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35545171
7.
Activation of the Intracellular Pattern Recognition Receptor NOD2 Promotes Acute Myeloid Leukemia (AML) Cell Apoptosis and Provides a Survival Advantage in an Animal Model of AML.
J Immunol
; 204(7): 1988-1997, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32094205
8.
Preclinical activity and a pilot phase I study of pacritinib, an oral JAK2/FLT3 inhibitor, and chemotherapy in FLT3-ITD-positive AML.
Invest New Drugs
; 38(2): 340-349, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31102119
9.
Fc-engineered anti-CD33 monoclonal antibody potentiates cytotoxicity of membrane-bound interleukin-21 expanded natural killer cells in acute myeloid leukemia.
Cytotherapy
; 22(7): 369-376, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32303428
10.
Molecular Complete Remission Following Ivosidenib in a Patient With an Acute Undifferentiated Leukemia.
J Natl Compr Canc Netw
; 18(1): 6-10, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31910380
11.
Considerations for Use of Hematopoietic Growth Factors in Patients With Cancer Related to the COVID-19 Pandemic.
J Natl Compr Canc Netw
; : 1-4, 2020 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32871558
12.
NCCN Guidelines Insights: Hematopoietic Growth Factors, Version 1.2020.
J Natl Compr Canc Netw
; 18(1): 12-22, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31910384
13.
A phase I study of lenalidomide plus chemotherapy with idarubicin and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome.
Am J Hematol
; 95(12): 1457-1465, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32777116
14.
Comparison of Two Doses of Antithymocyte Globulin in Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 25(10): 1993-2001, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31229641
15.
A Phase II Multicenter Study of the Addition of Azacitidine to Reduced-Intensity Conditioning Allogeneic Transplant for High-Risk Myelodysplasia (and Older Patients with Acute Myeloid Leukemia): Results of CALGB 100801 (Alliance).
Biol Blood Marrow Transplant
; 25(10): 1984-1992, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31212080
16.
BEAM versus BUCYVP16 Conditioning before Autologous Hematopoietic Stem Cell Transplant in Patients with Hodgkin Lymphoma.
Biol Blood Marrow Transplant
; 25(6): 1107-1115, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30716453
17.
None of the above: thrombotic microangiopathy beyond TTP and HUS.
Blood
; 129(21): 2857-2863, 2017 05 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-28416509
18.
Anti-leukemic effects of all-trans retinoic acid in combination with Daratumumab in acute myeloid leukemia.
Int Immunol
; 30(8): 375-383, 2018 07 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29868798
19.
Decitabine enhances anti-CD33 monoclonal antibody BI 836858-mediated natural killer ADCC against AML blasts.
Blood
; 127(23): 2879-89, 2016 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27013443
20.
The interleukin-3 receptor CD123 targeted SL-401 mediates potent cytotoxic activity against CD34+CD123+ cells from acute myeloid leukemia/myelodysplastic syndrome patients and healthy donors.
Haematologica
; 103(8): 1288-1297, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29773600